SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,384,813 | -61.7% | 7,696,055 | -12.4% | 0.01% | -60.0% |
| Q2 2023 | $413,293,429 | -30.5% | 8,789,737 | -38.0% | 0.04% | +29.6% |
| Q1 2023 | $594,450,078 | +137.9% | 14,167,066 | +116.2% | 0.03% | +8.0% |
| Q4 2022 | $249,873,862 | +1.0% | 6,551,491 | +3.7% | 0.02% | -3.8% |
| Q3 2022 | $247,395,000 | +28.1% | 6,317,534 | +5.7% | 0.03% | +36.8% |
| Q2 2022 | $193,060,000 | +3.6% | 5,977,093 | +6.1% | 0.02% | +26.7% |
| Q1 2022 | $186,403,000 | -20.2% | 5,631,525 | +2.6% | 0.02% | -11.8% |
| Q4 2021 | $233,570,000 | -6.5% | 5,490,574 | -2.6% | 0.02% | -15.0% |
| Q3 2021 | $249,780,000 | -35.9% | 5,637,084 | -17.8% | 0.02% | -35.5% |
| Q2 2021 | $389,810,000 | -40.5% | 6,861,659 | -21.6% | 0.03% | -44.6% |
| Q1 2021 | $655,483,000 | -2.9% | 8,757,289 | +12.2% | 0.06% | -6.7% |
| Q4 2020 | $675,357,000 | +41.7% | 7,806,699 | +0.1% | 0.06% | +25.0% |
| Q3 2020 | $476,500,000 | +47.2% | 7,796,140 | +0.1% | 0.05% | +33.3% |
| Q2 2020 | $323,811,000 | +44.8% | 7,787,672 | +0.0% | 0.04% | +16.1% |
| Q1 2020 | $223,633,000 | -60.1% | 7,786,668 | +0.2% | 0.03% | -50.0% |
| Q4 2019 | $561,106,000 | -48.4% | 7,772,629 | +0.3% | 0.06% | -52.3% |
| Q3 2019 | $1,087,044,000 | -22.6% | 7,748,548 | +1.0% | 0.13% | -20.7% |
| Q2 2019 | $1,404,695,000 | +16.1% | 7,672,154 | +0.8% | 0.16% | +13.1% |
| Q1 2019 | $1,210,091,000 | +79.6% | 7,608,239 | +8.2% | 0.14% | +57.6% |
| Q4 2018 | $673,698,000 | -31.9% | 7,033,076 | +0.5% | 0.09% | -17.1% |
| Q3 2018 | $988,700,000 | -9.5% | 6,999,644 | +0.3% | 0.11% | -11.9% |
| Q2 2018 | $1,092,169,000 | -1.3% | 6,977,378 | +1.6% | 0.13% | -3.8% |
| Q1 2018 | $1,106,019,000 | +7.7% | 6,866,691 | +10.1% | 0.13% | +9.2% |
| Q4 2017 | $1,027,381,000 | +193.6% | 6,237,519 | +11.1% | 0.12% | +185.7% |
| Q3 2017 | $349,886,000 | -21.6% | 5,616,162 | +0.3% | 0.04% | -23.6% |
| Q2 2017 | $446,139,000 | +12.3% | 5,601,943 | +0.2% | 0.06% | +10.0% |
| Q1 2017 | $397,319,000 | +39.6% | 5,590,527 | +0.3% | 0.05% | +31.6% |
| Q4 2016 | $284,663,000 | +12.9% | 5,575,076 | +1.8% | 0.04% | +11.8% |
| Q3 2016 | $252,100,000 | +74.2% | 5,474,480 | +13.9% | 0.03% | +70.0% |
| Q2 2016 | $144,758,000 | -5.9% | 4,804,432 | +0.1% | 0.02% | -4.8% |
| Q1 2016 | $153,831,000 | -39.0% | 4,798,228 | +10.9% | 0.02% | -38.2% |
| Q4 2015 | $252,338,000 | +38.0% | 4,328,270 | +0.1% | 0.03% | +30.8% |
| Q3 2015 | $182,907,000 | -41.2% | 4,321,989 | +1.3% | 0.03% | -35.0% |
| Q2 2015 | $311,308,000 | +60.1% | 4,264,489 | +10.2% | 0.04% | +60.0% |
| Q1 2015 | $194,456,000 | +37.3% | 3,871,303 | +0.1% | 0.02% | +38.9% |
| Q4 2014 | $141,601,000 | +16.6% | 3,868,893 | +0.3% | 0.02% | +12.5% |
| Q3 2014 | $121,489,000 | – | 3,856,789 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |